Sodium intake markedly alters renal interstitial fluid adenosine

Hypertension

Volumn 27, Issue 3 I, 1996, Pages 404-407

  Siragy, Helmy M ^a,b   Linden, Joel ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

adenosine; extracellular space; kidney; sodium

Indexed keywords

ADENOSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HYPERTENSION; INTERSTITIAL FLUID; KIDNEY MEDULLA; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM INTAKE;

EID: 0029975139     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.3.404     Document Type: Article

References (19)

1. Osswald H, Nabakowski G, Hermes H. Adenosine as a possible mediator of metabolic control of glomerular filtration rate. Int J Biochem. 1980;12:262-267.
2. Pawlowska D, Granger JP, Knox FG. Effects of adenosine infusion into renal interstitium on renal hemodynamics. Am J Physiol. 1987; 252:F678-F682.
3. Spielman WS, Arend LJ. Adenosine receptors and signaling in the kidney. Hypertension. 1991;17:117-130.
4. Ramos-Salazar A, Baines AD. Role of 5′-nucleotidase in adenosine-mediated renal vasoconstriction during hypoxia. J Pharmacol Exp Ther. 1986;236:494-499.
5. Baranowski RL, Westenfelder C. Estimation of renal interstitial adenosine and purine metabolites by microdialysis. Am J Physiol. 1994;267:F174-F182.
6. Siragy HM, Johns RA, Peach MJ, Carey RM. Nitric oxide alters renal function and guanosine 3′,5′-cyclic monophosphate. Hypertension. 1992;19:775-779.
7. Siragy HM, Jaffa AA, Margolius HS. Stimulation of renal interstitial bradykinin by sodium depletion. Am J Hypertens. 1993;6:863-866.
8. 2, and cyclic guanosine 3′,5′-monophosphate: effects of altered sodium intake. Hypertension. 1994;23:1068-1070.
9. Linden J, Taylor HE, Feldman MD, Woodward EB, Ayers CR, Ripley ML, Iflah S, Patel A. The precise radioimmunoassay of adenosine: minimization of sample collection artifacts and immunocrossreactivity. Anal Biochem. 1992;201:246-254.
10. Goodnight JH, Harvey WR. Least Square Means in the Fixed Effects General Linear Model. Cary, NC: SAS Institute; 1978. SAS technical report R-103.
11. Spielman WS. Antagonistic effect of theophylline on the adenosine-induced decrease in renin release. Am J Physiol. 1984;247:F246-F251.
12. Churchill PC, Bidani AK. Renal effects of selective adenosine receptor agonists. Am J Physiol. 1987;252:F299-F303.
13. Blanco J, Mallol J, Lluis C, Canela EI, Franco R. Adenosine metabolism in kidney slices under normoxic conditions. J Cell Physiol. 1990;143:344-351.
14. Arend LJ, Thompson CI, Brandt MA, Spielman WS. Elevation of intrarenal adenosine by maleic acid decreases GFR and renin release. Kidney Int. 1986;30:656-661.
15. Miller WL, Thomas RA, Berne RM, Rubio R. Adenosine production in the ischemic kidney. Circ Res. 1978;43:390-397.
16. Möser GH, Schrader J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol. 1989;256:C799-C806.
17. Darvicki DD, Agarwal KC, Parks RE. Adenosine metabolism in human whole blood. Biochem Pharmacol. 1988;37:621-626.
18. Lorenz JN, Weihprecht H, He XR, Skott O, Briggs JP, Schnermann J. Effects of adenosine and angiotensin on macula densa-stimulated renin secretion. Am J Physiol. 1993;265:F187-F194.
19. Osswald H, Mühlbauer B, Schenk F. Adenosine mediates tubuloglomerular feedback response: an element of metabolic control of kidney function. Kidney Int. 1991;39:S128-S131.